3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide

C104H130Cl4N40O16S3 — CID 159357135

IUPAC3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
SMILESCOc1ccc(C(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1S(=O)(=O)N(C)C1CCCCC1.Cc1cc(C)cc(S(=O)(=O)N2CCN(CC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)CC2)c1.Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)cc2)n1.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)CCc4c[nH]c5ccccc45)CC3)N2)nc1Cl
InChIInChI=1S/C28H33ClN12O5S.C27H36ClN9O5S.C26H35ClN10O4S.C23H26ClN9O2/c1-15-13-16(2)34-27(33-15)40-47(45,46)18-5-3-17(4-6-18)35-19(42)7-8-20(43)41-11-9-28(10-12-41)14-32-26(39-28)38-25(44)21-23(30)37-24(31)22(29)36-21;1-36(17-6-4-3-5-7-17)43(40,41)19-14-16(8-9-18(19)42-2)25(39)37-12-10-27(11-13-37)15-31-26(35-27)34-24(38)20-22(29)33-23(30)21(28)32-20;1-16-11-17(2)13-18(12-16)42(40,41)37-9-7-35(8-10-37)14-19(38)36-5-3-26(4-6-36)15-30-25(34-26)33-24(39)20-22(28)32-23(29)21(27)31-20;24-18-20(26)30-19(25)17(29-18)21(35)31-22-28-12-23(32-22)7-9-33(10-8-23)16(34)6-5-13-11-27-15-4-2-1-3-14(13)15/h3-6,13H,7-12,14H2,1-2H3,(H,35,42)(H4,30,31,37)(H,33,34,40)(H2,32,38,39,44);8-9,14,17H,3-7,10-13,15H2,1-2H3,(H4,29,30,33)(H2,31,34,35,38);11-13H,3-10,14-15H2,1-2H3,(H4,28,29,32)(H2,30,33,34,39);1-4,11,27H,5-10,12H2,(H4,25,26,30)(H2,28,31,32,35)
InChIKeyLIBJZNDNRSURSB-UHFFFAOYSA-N
MW2434.46 g/mol
LogP4.02
Rot. Bonds23

About 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide

3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide (PubChem CID 159357135) has the molecular formula C104H130Cl4N40O16S3 and a molecular weight of 2434.46 g/mol. Its IUPAC name is 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide.

Molecular Properties

Compound Name3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
PubChem CID159357135
Molecular FormulaC104H130Cl4N40O16S3
Molecular Weight2434.46 g/mol
Exact Mass2430.85
IUPAC Name3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
SMILESCOc1ccc(C(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1S(=O)(=O)N(C)C1CCCCC1.Cc1cc(C)cc(S(=O)(=O)N2CCN(CC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)CC2)c1.Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)cc2)n1.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)CCc4c[nH]c5ccccc45)CC3)N2)nc1Cl
InChIInChI=1S/C28H33ClN12O5S.C27H36ClN9O5S.C26H35ClN10O4S.C23H26ClN9O2/c1-15-13-16(2)34-27(33-15)40-47(45,46)18-5-3-17(4-6-18)35-19(42)7-8-20(43)41-11-9-28(10-12-41)14-32-26(39-28)38-25(44)21-23(30)37-24(31)22(29)36-21;1-36(17-6-4-3-5-7-17)43(40,41)19-14-16(8-9-18(19)42-2)25(39)37-12-10-27(11-13-37)15-31-26(35-27)34-24(38)20-22(29)33-23(30)21(28)32-20;1-16-11-17(2)13-18(12-16)42(40,41)37-9-7-35(8-10-37)14-19(38)36-5-3-26(4-6-36)15-30-25(34-26)33-24(39)20-22(28)32-23(29)21(27)31-20;24-18-20(26)30-19(25)17(29-18)21(35)31-22-28-12-23(32-22)7-9-33(10-8-23)16(34)6-5-13-11-27-15-4-2-1-3-14(13)15/h3-6,13H,7-12,14H2,1-2H3,(H,35,42)(H4,30,31,37)(H,33,34,40)(H2,32,38,39,44);8-9,14,17H,3-7,10-13,15H2,1-2H3,(H4,29,30,33)(H2,31,34,35,38);11-13H,3-10,14-15H2,1-2H3,(H4,28,29,32)(H2,30,33,34,39);1-4,11,27H,5-10,12H2,(H4,25,26,30)(H2,28,31,32,35)
InChIKeyLIBJZNDNRSURSB-UHFFFAOYSA-N
XLogP4.02
TPSA810.55 Ų
H-Bond Donors19
H-Bond Acceptors43
Rotatable Bonds23
Heavy Atoms167
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002434.46
LogP ≤ 54.02
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1043

Analyze 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The IUPAC name of 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide (CID 159357135) is 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide.
What is the SMILES notation for 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The canonical SMILES for 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide is COc1ccc(C(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1S(=O)(=O)N(C)C1CCCCC1.Cc1cc(C)cc(S(=O)(=O)N2CCN(CC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)CC2)c1.Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)cc2)n1.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)CCc4c[nH]c5ccccc45)CC3)N2)nc1Cl.
What is the InChIKey of 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The InChIKey is LIBJZNDNRSURSB-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H33ClN12O5S.C27H36ClN9O5S.C26H35ClN10O4S.C23H26ClN9O2/c1-15-13-16(2)34-27(33-15)40-47(45,46)18-5-3-17(4-6-18)35-19(42)7-8-20(43)41-11-9-28(10-12-41)14-32-26(39-28)38-25(44)21-23(30)37-24(31)22(29)36-21;1-36(17-6-4-3-5-7-17)43(40,41)19-14-16(8-9-18(19)42-2)25(39)37-12-10-27(11-13-37)15-31-26(35-27)34-24(38)20-22(29)33-23(30)21(28)32-20;1-16-11-17(2)13-18(12-16)42(40,41)37-9-7-35(8-10-37)14-19(38)36-5-3-26(4-6-36)15-30-25(34-26)33-24(39)20-22(28)32-23(29)21(27)31-20;24-18-20(26)30-19(25)17(29-18)21(35)31-22-28-12-23(32-22)7-9-33(10-8-23)16(34)6-5-13-11-27-15-4-2-1-3-14(13)15/h3-6,13H,7-12,14H2,1-2H3,(H,35,42)(H4,30,31,37)(H,33,34,40)(H2,32,38,39,44);8-9,14,17H,3-7,10-13,15H2,1-2H3,(H4,29,30,33)(H2,31,34,35,38);11-13H,3-10,14-15H2,1-2H3,(H4,28,29,32)(H2,30,33,34,39);1-4,11,27H,5-10,12H2,(H4,25,26,30)(H2,28,31,32,35).
What are the key properties of 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide has a molecular weight of 2434.46 g/mol, XLogP of 4.02, 23 rotatable bonds, 19 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-diamino-6-chloro-N-[8-[3-[cyclohexyl(methyl)sulfamoyl]-4-methoxybenzoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(3,5-dimethylphenyl)sulfonylpiperazin-1-yl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[4-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]anilino]-4-oxobutanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(1H-indol-3-yl)propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide is sourced from PubChem (CID 159357135), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).